High mobility group box 1 (HMGB1) acts as an “alarmin” to promote acute myeloid leukaemia progression

Inna M. Yasinska, Isabel Gonçalves Silva, Svetlana S. Sakhnevych, Laura Ruegg, Rohanah Hussain, Giuliano Siligardi, Walter Fiedler, Jasmin Wellbrock, Marco Bardelli, Luca Varani, Ulrike Raap, Steffen Berger, Bernhard F. Gibbs, Elizaveta Fasler-Kan, Vadim V. Sumbayev
  • OncoImmunology, February 2018, Taylor & Francis
  • DOI: 10.1080/2162402x.2018.1438109
The author haven't yet claimed this publicationThe author haven't yet claimed this publication

In partnership with: